Tim Keane

Check it out, we’re talking about Tim Keane, this guy’s the real deal in medtech. He’s a YC W22 alum, but honestly, his story is way more than just startup creds. Started out deep in the science game, PhD in Bioengineering from Pittsburgh, where he crushed it enough to snag NSF Fellowships and then went full-on international with a Marie Skłodowska-Curie and Whitaker Scholar at Imperial College London. Basically, he’s been around the block in top-tier research, always pushing the boundaries of regenerative medicine and biomaterials.

After all that, he jumped into the trenches, becoming a Postdoc at Imperial, working on the bleeding edge of healing tech. Then, in 2019, he took a detour into the medical device world as a Fellow at Texas Medical Center, soaking up the startup vibe and understanding what it really takes to bring cool science to life. All this background? It’s like a turbo boost for his own vision.

Fast forward to 2020, Tim co-founded TYBR Health, this is the dude’s brainchild, a company making a sprayable hydrogel that stops internal scarring after surgery. Think about it, saving people from those nasty post-op complications. The science behind it is legit; he’s got over 30 papers backing up the tech. And this ain’t just some lab project, TYBR jumped into YC’s Winter 2022 batch, so they’re serious about taking this thing to the next level.

What I love about Tim? It’s how his process screams passion for solving real problems. He’s not just doing science for science’s sake, he’s in it to make a difference, to change the game in medicine. That drive? It’s rooted in all his research, all his international experience, and his hustle to turn biotech into something that actually saves lives.

He’s based in Houston now, but his story? It’s global. It’s about the grind, the curiosity, and the no bullshit attitude needed to turn crazy ideas into real-world solutions. Tim Keane isn’t just another scientist or entrepreneur, he’s a legit innovator who’s here to crush it and make healthcare better. No Cap.